Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 32% ± 15% | |
peripheral blood | 19 studies | 36% ± 14% | |
brain | 18 studies | 39% ± 21% | |
eye | 9 studies | 34% ± 14% | |
prostate | 5 studies | 29% ± 10% | |
intestine | 5 studies | 21% ± 7% | |
pancreas | 4 studies | 37% ± 14% | |
placenta | 4 studies | 27% ± 5% | |
bone marrow | 4 studies | 30% ± 11% | |
uterus | 4 studies | 32% ± 14% | |
breast | 4 studies | 24% ± 3% | |
lymph node | 4 studies | 28% ± 4% | |
kidney | 3 studies | 24% ± 3% | |
liver | 3 studies | 45% ± 22% | |
adipose | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5624.36 | 1445 / 1445 | 100% | 57.47 | 183 / 183 |
ovary | 100% | 6216.91 | 180 / 180 | 100% | 124.16 | 430 / 430 |
brain | 100% | 8857.42 | 2638 / 2642 | 100% | 55.87 | 705 / 705 |
prostate | 100% | 7819.30 | 245 / 245 | 100% | 64.37 | 500 / 502 |
lung | 100% | 11138.42 | 578 / 578 | 100% | 77.13 | 1150 / 1155 |
intestine | 100% | 5899.91 | 966 / 966 | 99% | 49.65 | 524 / 527 |
uterus | 100% | 5123.56 | 170 / 170 | 99% | 65.67 | 456 / 459 |
stomach | 100% | 4991.45 | 359 / 359 | 99% | 52.68 | 284 / 286 |
breast | 100% | 6419.64 | 459 / 459 | 99% | 57.09 | 1110 / 1118 |
thymus | 100% | 7430.24 | 653 / 653 | 99% | 84.17 | 599 / 605 |
adrenal gland | 100% | 4660.02 | 258 / 258 | 97% | 34.29 | 222 / 230 |
skin | 100% | 5478.56 | 1807 / 1809 | 95% | 46.25 | 450 / 472 |
kidney | 99% | 3296.97 | 88 / 89 | 96% | 33.30 | 862 / 901 |
bladder | 100% | 5416.67 | 21 / 21 | 94% | 53.94 | 475 / 504 |
pancreas | 93% | 2566.94 | 305 / 328 | 97% | 51.26 | 173 / 178 |
liver | 76% | 1367.33 | 171 / 226 | 69% | 18.48 | 281 / 406 |
adipose | 100% | 5247.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 60.18 | 29 / 29 |
spleen | 100% | 8175.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 72.25 | 45 / 45 |
blood vessel | 100% | 7453.65 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 3494.32 | 820 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 4987.89 | 839 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 19.55 | 63 / 80 |
muscle | 60% | 1032.12 | 480 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050870 | Biological process | positive regulation of T cell activation |
GO_0001525 | Biological process | angiogenesis |
GO_0032680 | Biological process | regulation of tumor necrosis factor production |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0032655 | Biological process | regulation of interleukin-12 production |
GO_0006954 | Biological process | inflammatory response |
GO_0032653 | Biological process | regulation of interleukin-10 production |
GO_0032649 | Biological process | regulation of type II interferon production |
GO_0045428 | Biological process | regulation of nitric oxide biosynthetic process |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0060368 | Biological process | regulation of Fc receptor mediated stimulatory signaling pathway |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_2000439 | Biological process | positive regulation of monocyte extravasation |
GO_0050765 | Biological process | negative regulation of phagocytosis |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0006915 | Biological process | apoptotic process |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0032675 | Biological process | regulation of interleukin-6 production |
GO_0071349 | Biological process | cellular response to interleukin-12 |
GO_0016477 | Biological process | cell migration |
GO_1904669 | Biological process | ATP export |
GO_0022409 | Biological process | positive regulation of cell-cell adhesion |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009986 | Cellular component | cell surface |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0070053 | Molecular function | thrombospondin receptor activity |
GO_0086080 | Molecular function | protein binding involved in heterotypic cell-cell adhesion |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CD47 |
Protein name | Leukocyte surface antigen CD47 (Integrin-associated protein) CD47 molecule Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47) |
Synonyms | MER6 |
Description | FUNCTION: Adhesive protein that mediates cell-to-cell interactions . Acts as a receptor for thrombospondin THBS1 and as modulator of integrin signaling through the activation of heterotrimeric G proteins . Involved in signal transduction, cardiovascular homeostasis, inflammation, apoptosis, angiogenesis, cellular self-renewal, and immunoregulation . Plays a role in modulating pulmonary endothelin EDN1 signaling . Modulates nitrous oxide (NO) signaling, in response to THBS1, hence playing a role as a pressor agent, supporting blood pressure (By similarity). Plays an important role in memory formation and synaptic plasticity in the hippocampus (By similarity). Receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells . Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation . Positively modulates FAS-dependent apoptosis in T-cells, perhaps by enhancing FAS clustering (By similarity). Plays a role in suppressing angiogenesis and may be involved in metabolic dysregulation during normal aging . In response to THBS1, negatively modulates wound healing (By similarity). Inhibits stem cell self-renewal, in response to THBS1, probably by regulation of the stem cell transcription factors POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 (By similarity). May play a role in membrane transport and/or integrin dependent signal transduction . May prevent premature elimination of red blood cells (By similarity). . |
Accessions | ENST00000355354.13 [Q08722-3] ENST00000398258.7 Q08722 A0A2R8Y484 A0A0A1TSG4 ENST00000644850.1 ENST00000517766.5 H7BYS8 ENST00000361309.6 [Q08722-1] H0YC40 |